HNRNPA1P60

Across TCGA pan-cancer cohorts, HNRNPA1P60 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of HNRNPA1P60’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where HNRNPA1P60 RNA is repressed in tumor relative to normal tissue. In most cancer types HNRNPA1P60 is over-expressed in tumor, although a few such as PAAD show the opposite, repressed pattern.

PAAD, BLCA, and LUSC are the cancer types where HNRNPA1P60 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HNRNPA1P60 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Male	All	−0.100	.009	2	view →
BLCA	Male	IV	+0.070	.025	1	view →
LUSC	All	All	+0.039	.034	1	view →
LIHC	All	II,III,IV	+0.017	.031	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

HNRNPA1P60–PAAD

Open the PAAD breakdown →